MEDICAL FACILITIES CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.86 CAD | -0.91% |
|
-1.54% | +20.94% |
| Apr. 18 | Russia accuses Ukraine of shelling medical facilities and of killing medical staff | RE |
| Apr. 09 | Israel purchases 40,000 tents for Rafah evacuation, Israeli media says | RE |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 114.9 | 171.9 | 230 | 155.4 | 168.4 | 194.1 | - |
| Enterprise Value (EV) 1 | 114.9 | 203.4 | 248.6 | 206 | 168.4 | 194.1 | 194.1 |
| P/E ratio | 11.5 x | 19.7 x | 14.8 x | -39.5 x | 9.28 x | 8.1 x | 10.7 x |
| Yield | 19.3% | 4.03% | 3.07% | 3.88% | - | 2.99% | 2.99% |
| Capitalization / Revenue | 0.27 x | 0.44 x | 0.56 x | 0.37 x | 0.38 x | 0.45 x | 0.43 x |
| EV / Revenue | 0.27 x | 0.44 x | 0.56 x | 0.37 x | 0.38 x | 0.45 x | 0.43 x |
| EV / EBITDA | 1.19 x | 1.79 x | 2.21 x | 2.15 x | 1.9 x | 2.28 x | - |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 31,106 | 31,106 | 31,106 | 26,200 | 24,856 | 24,471 | - |
| Reference price 2 | 3.693 | 5.527 | 7.395 | 5.930 | 6.774 | 7.933 | 7.933 |
| Announcement Date | 3/12/20 | 3/11/21 | 3/10/22 | 3/9/23 | 3/14/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 421.5 | 389.9 | 411.7 | 414.4 | 445.6 | 429 | 454.7 |
| EBITDA 1 | 96.25 | 96.13 | 104.1 | 72.25 | 88.65 | 85.03 | - |
| EBIT | -3.058 | 67.79 | 77.36 | 34.94 | - | - | - |
| Operating Margin | -0.73% | 17.39% | 18.79% | 8.43% | - | - | - |
| Earnings before Tax (EBT) 1 | 4.442 | 41.78 | 50.89 | 17.5 | 52.32 | 56.1 | 56.8 |
| Net income 1 | 9.824 | 8.813 | 15.5 | -4.405 | 18.5 | 24.7 | 18.8 |
| Net margin | 2.33% | 2.26% | 3.76% | -1.06% | 4.15% | 5.76% | 4.13% |
| EPS 2 | 0.3200 | 0.2800 | 0.5000 | -0.1500 | 0.7300 | 0.9800 | 0.7400 |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.7110 | 0.2228 | 0.2268 | 0.2301 | - | 0.2370 | 0.2370 |
| Announcement Date | 3/12/20 | 3/11/21 | 3/10/22 | 3/9/23 | 3/14/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 99.04 | 116.4 | 102.6 | 102.5 | 102.2 | 107.1 | 109.2 | 109.5 | 104.6 | 122.3 | 106.8 | 107.9 | 106.2 | 125.5 |
| EBITDA | 23.34 | 31.95 | 19.82 | 21.54 | 15.61 | 15.28 | 19.14 | 21.22 | 17.74 | 30.53 | - | - | - | - |
| EBIT | 16.56 | 25.5 | 14.68 | 16.46 | 10.42 | -6.627 | 13.5 | - | - | - | - | - | - | - |
| Operating Margin | 16.72% | 21.91% | 14.31% | 16.06% | 10.2% | -6.19% | 12.36% | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | 0.833 | 22.51 | -3.209 | 27.53 | -8.709 | 1.894 | 11.32 | 10.23 | 7.502 | 23.27 | 13.1 | 13.5 | 11.7 | 17.7 |
| Net income 1 | -3.545 | 10.25 | -7.861 | 16.18 | -10.45 | -2.274 | 4.411 | 3.324 | -0.114 | 10.88 | 6.6 | 6.1 | 5.7 | 6.2 |
| Net margin | -3.58% | 8.81% | -7.66% | 15.78% | -10.23% | -2.12% | 4.04% | 3.04% | -0.11% | 8.9% | 6.18% | 5.65% | 5.37% | 4.94% |
| EPS 2 | -0.1100 | 0.3300 | -0.2600 | 0.1900 | -0.3500 | -0.0800 | 0.1700 | 0.1300 | -0.0100 | 0.3900 | 0.2600 | 0.2400 | 0.2300 | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/11/21 | 3/10/22 | 5/12/22 | 8/11/22 | 11/9/22 | 3/9/23 | 5/11/23 | 8/10/23 | 11/9/23 | 3/14/24 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | 31.5 | 18.5 | 50.7 | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 0.3276 x | 0.1779 x | 0.7013 x | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - |
| Cash Flow per Share | 2.490 | - | - | - | - | - | - |
| Capex | - | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - | - |
| Announcement Date | 3/12/20 | 3/11/21 | 3/10/22 | 3/9/23 | 3/14/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
7.933
USD
Average target price
8.134
USD
Spread / Average Target
+2.53%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +20.94% | 194M | |
| -20.16% | 16.21B | |
| +4.50% | 12.44B | |
| +3.98% | 11.58B | |
| +9.72% | 10.79B | |
| +23.61% | 8.26B | |
| -2.19% | 7.68B | |
| +20.75% | 7.2B | |
| +4.49% | 6.67B | |
| +50.89% | 4.66B |
- Stock Market
- Equities
- DR Stock
- Financials Medical Facilities Corporation
